Improved Detection of Transosseous Meningiomas Using 68 Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRI
Ga-DOTATATE PET/CT enables detection of meningioma tissue based on somatostatin receptor 2 expression. Transosseous extension of intracranial meningiomas is known to be an important risk factor for tumor recurrence and patient mortality. We analyzed the diagnostic performance of Ga-DOTATATE PET/CT a...
Gespeichert in:
Veröffentlicht in: | Journal of Nuclear Medicine 2017-10, Vol.58 (10), p.1580-1587 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Ga-DOTATATE PET/CT enables detection of meningioma tissue based on somatostatin receptor 2 expression. Transosseous extension of intracranial meningiomas is known to be an important risk factor for tumor recurrence and patient mortality. We analyzed the diagnostic performance of
Ga-DOTATATE PET/CT and contrast-enhanced MRI (CE-MRI) for the detection of osseous infiltration using qualitative and quantitative imaging parameters.
In this institutional review board-approved retrospective study, subjects were selected from 327 consecutive
Ga-DOTATATE PET/CT examinations for evaluation of confirmed or suspected meningioma. Inclusion criteria were CE-MRI within 30 d and pathology-confirmed meningioma diagnosis with inclusion or exclusion of transosseous extension as the standard of reference. Imaging was analyzed by two readers. Tracer uptake values and meningioma volumes were determined. χ
, Mann-Whitney U, Wilcoxon signed rank, and McNemar tests, as well as receiver-operating-characteristic analyses, were performed to compare variables and diagnostic performance.
Eighty-two patients fulfilled the inclusion criteria. Patients with transosseous extension of meningioma (
= 67) showed significantly larger lesions (median, 12.8 vs. 3.3 mL;
< 0.001) and significantly higher tracer uptake values (median SUV
, 14.2 vs. 7.6;
= 0.011) than patients with extraosseous meningiomas (
= 15).
Ga-DOTATATE PET/CT in comparison to CE-MRI performed at a higher sensitivity (98.5% vs. 53.7%) while maintaining high specificity (86.7% vs. 93.3%) in the detection of osseous involvement (
< 0.001). In receiver-operating-characteristic analysis, PET/CT assessment performed better than CE-MRI (area under the curve, 0.932 vs. 0.773). PET/CT- and CE-MRI-based volume estimation yielded comparable results for extraosseous meningiomas (
= 0.132) and the extraosseous part of transosseous meningiomas (
= 0.636), whereas the volume of the intraosseous part was assessed as significantly larger by PET/CT (
< 0.001).
Ga-DOTATATE PET/CT enables improved detection of the transosseous extension of intracranial meningiomas compared with CE-MRI. |
---|---|
ISSN: | 0161-5505 1535-5667 2159-662X |
DOI: | 10.2967/jnumed.117.191932 |